(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 44.94% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 115.33%, and while it is forecast to beat the US market's average forecast revenue growth rate of 24.07%.
Zai Lab's revenue in 2026 is $441,629,000.On average, 11 Wall Street analysts forecast ZLAB's revenue for 2026 to be $622,985,709,456, with the lowest ZLAB revenue forecast at $542,993,242,848, and the highest ZLAB revenue forecast at $749,217,427,120. On average, 9 Wall Street analysts forecast ZLAB's revenue for 2027 to be $809,070,770,032, with the lowest ZLAB revenue forecast at $667,997,369,776, and the highest ZLAB revenue forecast at $939,438,694,320.
In 2028, ZLAB is forecast to generate $1,671,071,713,600 in revenue, with the lowest revenue forecast at $1,300,582,617,600 and the highest revenue forecast at $2,089,116,126,400.